Neogen (NEOG) Competitors $4.74 -0.12 (-2.47%) Closing price 04:00 PM EasternExtended Trading$4.73 -0.01 (-0.19%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Haemonetics (NYSE:HAE) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Is HAE or NEOG more profitable? Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Haemonetics12.32% 26.37% 9.22% Neogen -53.56%2.69%1.82% Which has better valuation & earnings, HAE or NEOG? Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHaemonetics$1.36B2.56$167.68M$3.3121.92Neogen$924.22M1.11-$9.42M-$2.23-2.13 Which has more risk & volatility, HAE or NEOG? Haemonetics has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500. Do analysts recommend HAE or NEOG? Haemonetics currently has a consensus target price of $97.30, suggesting a potential upside of 34.11%. Neogen has a consensus target price of $7.50, suggesting a potential upside of 58.23%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Haemonetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Haemonetics 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to HAE or NEOG? In the previous week, Neogen had 11 more articles in the media than Haemonetics. MarketBeat recorded 26 mentions for Neogen and 15 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.43 beat Neogen's score of 0.32 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Neogen 7 Very Positive mention(s) 0 Positive mention(s) 13 Neutral mention(s) 6 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in HAE or NEOG? 99.7% of Haemonetics shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 1.8% of Haemonetics shares are held by insiders. Comparatively, 1.1% of Neogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryHaemonetics beats Neogen on 14 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05B$10.12B$5.52B$9.41BDividend YieldN/A2.05%3.80%4.04%P/E Ratio13.5016.5928.0419.84Price / Sales1.1129.60429.5399.59Price / Cash4.7422.2635.8457.94Price / Book0.333.578.125.65Net Income-$9.42M$235.43M$3.25B$258.00M7 Day Performance-12.06%-1.67%0.97%2.09%1 Month Performance-5.01%2.91%7.36%11.13%1 Year Performance-71.89%-16.44%31.31%18.40% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen4.1545 of 5 stars$4.74-2.5%$7.50+58.2%-72.3%$1.05B$924.22M-2.132,110Trending NewsHAEHaemonetics4.8923 of 5 stars$75.00-2.4%$96.80+29.1%-18.7%$3.60B$1.36B22.663,023ICUIICU Medical4.3776 of 5 stars$129.71-4.2%$192.67+48.5%-2.5%$3.19B$2.38B-33.8715,000News CoveragePositive NewsXRAYDENTSPLY SIRONA4.5287 of 5 stars$15.94-4.4%$20.36+27.8%-42.7%$3.18B$3.79B-3.5114,000Analyst RevisionQDELQuidelOrtho4.454 of 5 stars$29.22-3.2%$44.33+51.7%-23.4%$1.98B$2.78B-5.886,600News CoverageGap UpSTAASTAAR Surgical3.3378 of 5 stars$16.61-7.0%$24.63+48.3%-61.0%$822.63M$279.13M-11.531,211Analyst ForecastGap UpCERSCerus2.6677 of 5 stars$1.45-5.8%$3.50+141.4%-41.9%$277.18M$180.27M-14.50290Positive NewsOSUROraSure Technologies2.5804 of 5 stars$3.05-1.0%$3.00-1.6%-26.3%$228.14M$185.83M-7.26840UTMDUtah Medical Products2.1718 of 5 stars$57.19-2.1%N/A-22.9%$185.87M$40.90M15.13180Positive NewsUpcoming EarningsANIKAnika Therapeutics4.3265 of 5 stars$10.81-3.9%$20.00+85.0%-60.9%$155.02M$119.91M-2.79300WSTWest Pharmaceutical Services4.8069 of 5 stars$221.49-0.3%$320.00+44.5%-32.2%$15.91B$2.90B34.7710,600Positive NewsUpcoming Earnings Related Companies and Tools Related Companies HAE Competitors ICUI Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.